1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Large B-cell Lymphoma: new trials by email Literature Review of Large B-cell Lymphoma trials Research Report on Large B-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma CNCT19, Gemcitabine Injection, busulfan - Large B-cell Lymphoma | Phase 1 / Phase 2 | Completed | Institute of Hematology & Blood Diseases Hospital, China | 30 | 2021-01-01 | 2025-05-13 |
Busulfan (1) · Gemcitabine (1) · Melphalan (1)
Institute of Hematology & Blood Diseases Hospital, China (1)
China (1)
Dehui Zou, Dr. (1)